About this trial
Spectral CT was used to prospectively collect medical images and clinical data related to breast cancer, evaluate the effect of image quality in the diagnosis of breast cancer, and evaluate the application value in the accurate staging of breast cancer, so as to provide a more accurate clinical basis for diagnosis, promote the development of individualized treatment, and ultimately improve the prognosis of patients.
Eligibility criteria
Qualifiers
(a) Chest quark energy spectrum CT examination was performed within 1 week before treatment
(b) Age ≥ 18
(c) Suspected breast cancer patients
(d) Patients who signed informed consent
Disqualifiers
(a) Severe cardiac, pulmonary and renal insufficiency
(b) Allergic to iodine contrast media
(c) Unable to cooperate to complete CT examination
(d) Quark spectrum CT image is poor and cannot be used
Trial design
Treatments tested in this trial
- To explore the value of spectral CT in the diagnosis and treatment of breast cancer